MCLEAN, VA, May 23, 2011 (Press-News.org) ZyLAB, a leading eDiscovery and information management technology company, today announced that it was positioned by Gartner, Inc. as a "Visionary" among the 24 eDiscovery software vendors selected for inclusion in the firm's inaugural "Magic Quadrant for E-Discovery Software" report.
ZyLAB's position in the visionary quadrant is based upon Gartner's analysis of the company's ability to execute and its completeness of vision. ZyLAB has demonstrated its keen understanding of buyers' wants and needs and the ability to translate that understanding into products and services.
"We believe ZyLAB's recognition among the biggest players in the eDiscovery market is a solid testament to our strategy and the quality of our technology," said Pieter Varkevisser, CEO of ZyLAB. "ZyLAB has meticulously applied its pioneering information search and retrieval software as the core of a modular eDiscovery system that has been proven in the largest corporate fraud investigations, the largest criminal case in US history, and the historic United Nations war crime tribunals."
Over the last several quarters, ZyLAB has significantly increased its strategic investments to support the considerable growth in its eDiscovery operations in North America. "As revenue and market share are growing rapidly in the US, we have recruited renowned thought leaders and strategic advisors for our US team and we are very pleased to welcome several top AmLaw firms to our client portfolio," continued Varkevisser.
ZyLAB is among an elite sub-group of vendors that fully addresses the left-side and right-side of the Electronic Discovery Reference Model (EDRM) as well as provides information management. The company's long heritage in search and information retrieval has fueled its strengths in ECA, identification, collection, preservation, processing, review and production.
To learn more about ZyLAB's eDiscovery and information management software and services, please visit www.zylab.com or call 1-866-995-2262 ext. 827.
About ZyLAB
ZyLAB's industry-leading, modular eDiscovery and enterprise information management solutions enable organizations to manage boundless amounts of enterprise data in any format and language, to mitigate risk, reduce costs, investigate matters and elicit business productivity and intelligence.
The ZyLAB eDiscovery system is directly aligned with the Electronic Discovery Reference Model (EDRM) and the company's products and services are used on an enterprise level by corporations, government agencies, courts, and law firms, as well as on specific projects for legal services, auditing, and accounting providers. ZyLAB systems are also available in a Software-as-a-Services (SaaS) model.
ZyLAB has received numerous industry accolades and is one of the few companies to be positioned as a Leader in Gartner's "Magic Quadrant for Information Access Technology" for 2007, 2008 and 2009. In addition, Gartner has given ZyLAB the highest rating ("Strong Positive") in its "MarketScope for E-Discovery and Litigation Support Vendors" for 2007, 2008 and 2009, as well as a "Promising" rating in its 2008 "MarketScope for Records Management".
Headquartered in Amsterdam, the Netherlands and McLean, Virginia, ZyLAB also serves local markets from regional offices in New York, Barcelona, Frankfurt, London, Paris, and Singapore. To learn more about ZyLAB visit www.zylab.com.
About the Magic Quadrant
The Magic Quadrant is copyrighted 2011 by Gartner, Inc., and is reused with permission. The Magic Quadrant is a graphical representation of a marketplace at and for a specific time period. It depicts Gartner's analysis of how certain vendors measure against criteria for that marketplace, as defined by Gartner. Gartner does not endorse any vendor, product or service depicted in the Magic Quadrant, and does not advise technology users to select only those vendors placed in the "Leaders" quadrant. The Magic Quadrant is intended solely as a research tool, and is not meant to be a specific guide to action. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
ZyLAB's products and services are used on an enterprise level by corporations, government agencies, courts, and law firms, as well as on specific matters for legal services, auditing, and accounting providers. For more information, please call 1-866-995-2262.
ZyLAB Positioned as a "Visionary" in Leading Global Research Firm's New "Magic Quadrant for E-Discovery Software" Report
Company positioned by Gartner, Inc. as a "Visionary" among the 24 eDiscovery software vendors selected for inclusion in the firm's inaugural "Magic Quadrant for E-Discovery Software" report.
2011-05-23
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Genomics and social network analysis team up to solve disease outbreaks
2011-05-23
NEW ORLEANS, LA – May 22, 2011 -- Combining the cutting-edge technology of whole genome sequencing of bacteria with social networking analysis, public health officials can get a more detailed picture of disease outbreaks that will better help track and stop them, say researchers today at the 111th General Meeting of the American Society for Microbiology.
"Public health agencies are now able to harness the power of genome sequencing, which, when combined with the detailed clinical and epidemiological data we have access to, allows us to reconstruct outbreaks and really ...
Telemonitoring can improve overall survival of HF patients
2011-05-23
May 22, 2011 –Gothenburg, Sweden: Two trials presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology (HFA of the ESC), will help to define the precise populations of patients with chronic heart failure (CHF) in whom telemedical management delivers benefits. Both the TIM-HF and TEHAF studies - presented in Late Breaking Session 1 - revealed that telemonitoring showed significant benefits in defined subgroups of patients. The results, which will be used to help in the design of future trials, come ...
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
2011-05-23
May 22, 2011- Gothenburg, Sweden : The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology (ESC). The analysis, presented in Late Breaking Session 1, furthermore showed that the beneficial effects of eplerenone in reducing major CV events were similar in patients with ...
Heart Failure: Targeting the right patients for CRT-D
2011-05-23
Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation, concludes the latest analysis of the MADIT CRT trial. The CRT-MADIT-CRT trial - presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology (ESC) in Late Breaking Session 1 - showed that CRT produced improvements in both synchrony and contractile function, and that the extent of this benefit relates to subsequent outcomes.
The Multicentre Automatic Defibrillator ...
UBC-led team develops platform to monitor hematopoietic stem cells
2011-05-23
A Canadian research team has developed an automated microfluidic cell culture platform to monitor the growth, survival and responses of hundreds of hematopoietic stem cells (HSCs) at the single cell level.
This new tool allows scientists to study multiple temporally varying culture conditions simultaneously and to gain new insights on the growth factor requirements for HSC survival.
"The ability to perform massively parallel cultures of single non-adherent mammalian cells will provide new avenues to explore complex biological questions," says Véronique Lecault, lead ...
Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis
2011-05-23
A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor (TNF), can also suppress aspects of inflammation. The researchers say the identification of the mechanism of how this occurs could potentially lead to new treatments for diseases such as rheumatoid arthritis. The study was published May 22 online in advance of publication in the journal Nature Immunology.
"Prior to this study, TNF has long been known as a potent pro-inflammatory cytokine, but if you look carefully through ...
Adevarul Chooses Locklizard PDF DRM Security to Secure Ebooks
2011-05-23
Adevarul, Romania's premier integrated multimedia business publishing magazines such as OK!, Forbes, etc. chooses LockLizard Safeguard Enterprise PDF DRM to secure ebooks in their new ebook shop, www.adevarulshop.ro.
Adevarul had been looking to provide digital products and take a leading position in the rapidly developing ebook marketplace, but concerns over piracy and associated loss of revenue had prevented them from pursuing this avenue further. Enter LockLizard with their PDF DRM software - a DRM solution for secure ebooks in PDF format. LockLizard PDF DRM has been ...
Scientists find new drug target in breast cancer
2011-05-23
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.
In a mouse model of breast cancer, blocking production of the protein using genetic techniques caused tumours to shrink. The scientists are now looking for new drugs which could achieve a similar effect.
Breast cancer is the most common cancer in the UK, affecting about 46,000 women each year. More than two thirds of breast tumours contain oestrogen receptors, meaning that ...
Gulf currents primed bacteria to degrade oil spill
2011-05-23
A new computer model of the Gulf of Mexico in the period after the oil spill provides insights into how underwater currents may have primed marine microorganisms to degrade the oil.
"It is called dynamic auto-inoculation. Parcels of water move over the ruptured well, picking up hydrocarbons. When these parcels come back around and cross back over the well, the bacteria have already been activated, are more abundant than before, and degrade hydrocarbons far more quickly," says David Valentine of the University of California, Santa Barbara, speaking today at the 111th ...
Page 1 Solutions Launches New Company Website Design and Logo
2011-05-23
Page 1 Solutions, a Colorado-based Internet marketing and website design agency, just launched a new website design and new logo for the company on May 17th, 2011. Page 1 offers Web marketing services to attorneys, dentists, plastic surgeons, and ophthalmologists across the U.S. and Canada.
It has been three years since Page 1 has had a new website design and the timing was perfect for the new site to go live. It was launched right before the American Academy of Cosmetic Dentistry (AACD) meeting in Boston, MA, where Page 1 is exhibiting. Spring and summer are busy travel ...
LAST 30 PRESS RELEASES:
Special issue of APA’s official journal focuses on psychedelic medication
Geneticist unlocks mysteries of childhood psychiatric disorders through innovative research
New study uncovers key insights into protein interactions in Duchenne muscular dystrophy, paving way for more targeted therapies
Revolutionizing fragrance design using deep neural networks (DNNs) scent profiles from chemical data
Custom-fit bone grafts: the future of craniomaxillofacial surgery
A new ‘molecular lantern’ detects brain metastasis in mice by inserting a probe thinner than a hair into the brain
McGill scientist reveals how early life experiences reshape our genes and brain health
Renowned scientist reveals vital link between inflammation and depression through groundbreaking research
Medical researcher explores economic impact of psychedelic therapy implementation
Improving immunotherapies for kidney cancer
Billing patients for portal messages could decrease message volume and ease physician workload
Study of Sherpas highlights key role of kidneys in acclimatization to high altitudes
Smartphone app can help reduce opioid use and keep patients in treatment, UT Health San Antonio study shows
Improved health care value cannot be achieved by hospital mergers and acquisitions alone
People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination
Does coffee prevent head and neck cancer?
AI replaces humans in identifying causes of fuel cell malfunctions
Pitfalls of FDA-approved germline cancer predisposition tests
A rising trend of 'murderous verbs' in movies over 50 years
Brain structure differences are associated with early use of substances among adolescents
Pain coping skills training for patients receiving hemodialysis
Trends of violence in movies during the past half century
Major depressive disorder and driving behavior among older adults
John Howington, MD, MBA, FCCP, to become the 87th President of the American College of Chest Physicians
Preclinical study finds surges in estrogen promote binge drinking in females
Coming AI economy will sell your decisions before you take them, researchers warn
NASA’s Parker Solar Probe makes history with closest pass to Sun
Are we ready for the ethical challenges of AI and robots?
Nanotechnology: Light enables an "impossibile" molecular fit
Estimated vaccine effectiveness for pediatric patients with severe influenza
[Press-News.org] ZyLAB Positioned as a "Visionary" in Leading Global Research Firm's New "Magic Quadrant for E-Discovery Software" ReportCompany positioned by Gartner, Inc. as a "Visionary" among the 24 eDiscovery software vendors selected for inclusion in the firm's inaugural "Magic Quadrant for E-Discovery Software" report.